Drug factory · FDA FEI 3002646390
Taiho Pharmaceutical Co., Ltd.
200-22, Motohara, Kamikawa-machi, Kodama-gun, Japan
No problems found at FDA's last inspection, Oct 13, 2023.
No Action Indicated: inspectors found no objectionable conditions.
2 drug inspections on record since 2015: 2 with no problems, 0 with problems fixed voluntarily, 0 with FDA action.
What it does, for whom
| Drug | Role | For | NDC |
|---|---|---|---|
| Tipiracil and Trifluridine | Makes the active ingredient and tests it | Taiho Pharmaceutical Co., Ltd. | 64842-1020, 64842-1025 |
FDA inspection history
| Ended | Result | Program | Problems noted |
|---|---|---|---|
| Oct 13, 2023 | No problems found | Drug Quality Assurance | — |
| May 15, 2015 | No problems found | Drug Quality Assurance | — |
Registered with FDA for: analysis; api manufacture.